Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, today announced the launch of its solution, Precision Nudging® for Life Sciences, developed to help pharmaceutical and biotechnology companies deliver adaptive, behaviorally informed messaging directly to patients and caregivers across every stage of the treatment journey.
Lirio’s AI-driven Precision Nudging® solution is now available in Microsoft Marketplace, enabling healthcare organizations to deploy hyper-personalized behavioral interventions directly within Microsoft’s secure cloud ecosystem.
Lirio, a pioneer in the union of behavioral science and artificial intelligence to deliver better health outcomes, today announced the appointment of its first-ever advisory board, bringing together a mix of experts across health systems, life sciences, retail health, health plans and digital health to help strengthen the company’s position as a pioneer in AI-powered patient engagement.
A new market report highlights that health systems’ biggest challenges include personalizing engagement content (such as text messages and emails) at the patient level, ensuring patients actively engage with outreach efforts, and automating communications to reduce staff burden.
Genomics isn’t the be all and end all for success in personalized medicine–health systems and payers need to support behavior change using AI-powered solutions.
CMS is retiring the Health Equity Index (HEI), introduced to incentivize plans to reduce disparities in Medicare Advantage, and proposing the Excellent Health Outcomes for All (EHO4all) reward—offering payers challenges and opportunities.